Organisation
- Acronym
- ARC
- Role
- Partner
- Country
- FR
- Address
- 9 rue Guy Môquet – BP 90003 – 94803 Villejuif Cedex
- Website
- https://www.fondation-arc.org/
Partner
FR
FR
Fondation ARC for cancer research
ARC
Programme phases
2
TRANSCAN-2
2015–2021
View phase
TRANSCAN-3
2021–2027
View phase
Funding participation
Joint calls funded by this organisation.
Funded projects
Projects linked to this funding organisation.
BRCAddict
BRCAddict – Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors
JTC 2017
View project
CCE Breast
Clinical Impact of Intratumor heterogeneity in metastatic breast cancer
JTC 2014
View project
CHRYSALIS
Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian Cancer through multiOMICS analysis
JTC 2021
View project
CLEARLY
Validation of multiparametric models and Circulating and imaging biomarkers to improve Lung cancer EARLY detection.
JTC 2016
View project
EpiMARK
An integrated approach for epigenetic risk assessment and biomarker development for breast cancer in prospective cohorts / Identifying early epigenetic predictors of breast cancer risk and their etiology determinants
JTC 2012
View project
EPIPROPER
Identifying EPIgenetic determinants and biomarkers of drug resistance via characterization of PROspective PERsister cells
JTC 2023
View project
ERANET-PLL
Implementation of (epi)genetic and metabolic networks in the targeting of T-cell prolymphocytic leukemia
JTC 2017
View project
Euro MDS
An integrated european platform to conduct translational studies in myelodysplastic syndromes based on the EuroBloodNet infrastructure
JTC 2017
View project
EuroTCLym
Translational Research in Peripheral T-Cell Lymphomas: from characterization to novel targets
JTC 2017
View project
EXPLORE-NB
Exploring the epigenetic neuroblastoma landscape to improve measurable disease monitoring, disease understanding and personalized treatment
JTC 2023
View project
GLIO-COMBO
Targeting tumor heterogeneity in pediatric high-grade gliomas
JTC 2024
View project
GLIOMA-PRD
Multiparameric Analysis of the Evolution and Progression of Low-Grade Glioma (LGG)
JTC 2016
View project
HEPAMUT
Mutated neo-antigens in hepatocellular carcinoma
JTC 2015
View project
HLALOSS
New technologies for early detection of HLA loss leukemia relapse after allogeneic hematopoietic stem cell transplantation, and identification of relevant risk factors
JTC 2012
View project
IdeaTMEHCC
Identification of therapeutic targets using HCC DErived organoid Augmented with TME components.
JTC 2022
View project
iMMunocell
Single-cell immunophenotypic and transcriptomic profiling for minimally-invasive detection of early multiple myeloma
JTC 2016
View project
IMMUNOSCOR
Integrative cancer-immunology and Immunoscore for cancer classification and immunotherapies
JTC 2013
View project
IMMUSPHINX
Targeting sphingolipid metabolism to improve anti-melanoma immune therapies
JTC 2015
View project
LIQUIDHOPE
Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastoma
JTC 2017
View project
Ma.Tr.OC
Identification of molecular therapeutic targets and diagnostic/prognostic biomarkers for Malignant Transformation of Osteochondromas
JTC 2012
View project
MetaboCCC
Metabolomic profiles throughout the continuum of colorectal cancer
JTC 2012
View project
METRICs
Metabolism/Metagenomics-based strategies for sensitization to Radio- and Immuno- therapy Combinations.
JTC 2024
View project
MOLCARUTUC
Comprehensive genomic characterization of upper urinary tract urothelial carcinoma and paired bladder recurrences
JTC 2017
View project
NIRBTEST
New strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles.
JTC 2016
View project
NOVEL
Employing NGS technology for improved, non-invasive early detection, staging and prediction of progression in lymphoma patients
JTC 2016
View project
ONTHETRRAC
Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe
JTC 2014
View project
PERIMMUNE
INTRAPERITONEAL IMMUNE MODULATION FOR COLORECTAL PERITONEAL METASTASES
JTC 2021
View project
PMTR-pNET
Predictive models of therapy response in pancreatic neuroendocrine tumors
JTC 2017
View project
PROLIPSY
Early Detection of Prostate Cancer by Liquid Biopsies
JTC 2016
View project
Pur-Ther
New immunotherapies targeting the key purinergic checkpoints in the tumor microenvironment
JTC 2021
View project
R.E.ST.ING
Non-invasive prognostic markers for Resected Early-STage NSCLC: role of circulatING and exosomal miRNAs and free circulating DNA
JTC 2016
View project
ROCSANbio
Anti-PD1 and Niraparib (PARPi) combination therapy in gynae carcinosarcoma: Identification of response-predictive biomarkers and resistance mechanisms
JTC 2017
View project
SCIE-PANC
Stromal Compartment and Immune Epigenome spatial networks to counter therapy evasion in PANcreatic Cancer
JTC 2023
View project
THRuST
Early detection of relapses in stage II-III colon cancer patients by following a personalized molecular signature from a blood test: THRuST
JTC 2016
View project
TORPEDO
Targeting Of Resistance in PEDiatric Oncology (TORPEDO)
JTC 2014
View project
TRANSCALL-2
Integration of genetic biomarkers and early Minimal Residual Disease to improve risk stratification and cure in childhood Acute Lymphoblastic Leukemia
JTC 2016
View project